Clinical and paraclinical features of hepatocellular carcinoma in young patients

  • Nguyễn Công Long Bệnh viện Bạch Mai
  • Nguyễn Văn Khanh Bệnh viện Bạch Mai

Main Article Content

Keywords

HCC, hepatitis B virus, young patient

Abstract

Objective: The aims of the study were to describe the clinical and laboratorial features and the correlation between AFP levels and tumor number and diameter of hepatocellular carcinoma (HCC) in young adults. Subject and method: Patients diagnosed with HCC at the age of less than 40 years were collected of age, sex, hepatitis B, C virus infection status, liver function, sizes and numbers of tumors, and AFP levels. This was a descriptive study on 48 patients admitted at Bach Mai Hospital from January 2017 to December 2021. Result: Our study group included 37 male and 11 female patients (mean 34.4 years old); 42/48 patients were over 30 years old (87.8%); 43/48 (89.6%) patients with hepatitis B virus and 43/48 (89.6%) patients with good liver function (Child-Pugh A/B). There was an insignificant correlation between AFP levels and the numbers and size groups of tumors. Conclusion: Early-onset HCC was observed in young people with obvious risk factors for hepatitis B infection. It is necessary to closely monitor the group of subjects with chronic hepatitis B virus for early detection of HCC.

Article Details

References

1. Kwak HW, Park JW, Nam BH et al (2014) Clinical outcomes of a cohort series of patients with hepatocellular carcinoma in a hepatitis B virus-endemic area. J Gastroenterol Hepatol 29(4): 820-829. doi:10.1111/jgh.12470.
2. Carr BI, Guerra V, Giannini EG et al (2014) Significance of platelet and AFP levels and liver function parameters for HCC size and survival. Int J Biol Markers 29(3): 215-223. doi:10.5301/ jbm.5000064.
3. Yamazaki Y, Kakizaki S, Sohara N et al (2007) Hepatocellular carcinoma in young adults: The clinical characteristics, prognosis, and findings of a patient survival analysis. Dig Dis Sci 52(4): 1103-1107. doi:10.1007/s10620-006-9578-2.
4. Omata M, Cheng AL, Kokudo N et al (2017) Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: A 2017 update. Hepatol Int 11(4): 317-370. doi:10.1007/s12072-017-9799-9.
5. Giannini EG, Marenco S, Borgonovo G et al (2012) Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. Hepatology 56(4): 1371-1379. doi:10.1002/hep.25814.
6. Kim JH, Choi MS, Lee H et al (2006) Clinical features and prognosis of hepatocellular carcinoma in young patients from a hepatitis B-endemic area. J Gastroenterol Hepatol 21(3): 588-594. doi:10.1111/j.1440-1746.2005.04127.
7. Wan DW, Tzimas D, Smith JA et al (2011) Risk factors for early-onset and late-onset hepatocellular carcinoma in Asian immigrants with hepatitis B in the United States. Am J Gastroenterol 106(11): 1994-2000. doi:10.1038/ajg.2011.302.
8. Chan AJ, Balderramo D, Kikuchi L et al (2017) Early age hepatocellular carcinoma associated with hepatitis B infection in South America. Clin Gastroenterol Hepatol 15(10): 1631-1632. doi:10.1016/j.cgh.2017.05.015.
9. Furuta T, Kanematsu T, Matsumata T et al (1990) Clinicopathologic features of hepatocellular carcinoma in young patients. Cancer 66(11): 2395-2398.
10. Zeng J, Lin K, Liu H et al (2020) Prognosis factors of young patients undergoing curative resection for hepatitis B virus-related hepatocellular carcinoma: A multicenter study. Cancer Manag Res 12: 6597-6606. doi:10.2147/CMAR.S261368.